相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Impaired Fitness and Transmission of Macrolide-Resistant Campylobacter jejuni in Its Natural Host
Taradon Luangtongkum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Campylobacter antimicrobial resistance in Peru: a ten-year observational study
Simon Pollett et al.
BMC INFECTIOUS DISEASES (2012)
Transcriptional Regulation of the CmeABC Multidrug Efflux Pump and the KatA Catalase by CosR in Campylobacter jejuni
Sunyoung Hwang et al.
JOURNAL OF BACTERIOLOGY (2012)
Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action
Krishna Kannan et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS: ANTIBIOTICS THAT TARGET THE RIBOSOME (2011)
Ribosomal Mutations as the Main Cause of Macrolide Resistance in Campylobacter jejuni and Campylobacter coli
Mirva Lehtopolku et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Contribution of CmeG to antibiotic and oxidative stress resistance in Campylobacter jejuni
Byeonghwa Jeon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Impact of erythromycin resistance on the virulence properties and fitness of Campylobacter jejuni
Yassir A. Almofti et al.
MICROBIAL PATHOGENESIS (2011)
Crystal structures of CmeR-bile acid complexes from Campylobacter jejuni
Hsiang-Ting Lei et al.
PROTEIN SCIENCE (2011)
Structures of AcrR and CmeR: Insight into the mechanisms of transcriptional repression and multi-drug recognition in the TetR family of regulators
Mathew D. Routh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
23S rRNA Gene Mutations Contributing to Macrolide Resistance in Campylobacter jejuni and Campylobacter coli
Scott R. Ladely et al.
FOODBORNE PATHOGENS AND DISEASE (2009)
Antibiotic resistance in Campylobacter: emergence, transmission and persistence
Taradon Luangtongkum et al.
FUTURE MICROBIOLOGY (2009)
Fitness cost of macrolide resistance in Campylobacter jejuni
Feifei Han et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
23S rRNA Mutation A2074C Conferring High-Level Macrolide Resistance and Fitness Cost in Campylobacter jejuni
Haihong Hao et al.
MICROBIAL DRUG RESISTANCE (2009)
Development, Stability, and Molecular Mechanisms of Macrolide Resistance in Campylobacter jejuni
Dave Bryson Caldwell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
CmeR functions as a pleiotropic regulator and is required for optimal colonization of Campylobacter jejuni in vivo
Baoqing Guo et al.
JOURNAL OF BACTERIOLOGY (2008)
Trends of Norfloxacin and Erythromycin Resistance of Campylobacter jejuni/Campylobacter coli Isolates Recovered From International Travelers, 1994 to 2006
Erika R. Vlieghe et al.
JOURNAL OF TRAVEL MEDICINE (2008)
Key role of mfd in the development of fluoroquinolone resistance in Campylobacter jejuni
Jing Han et al.
PLOS PATHOGENS (2008)
Crystal structure of the transcriptional regulator CmeR from Campylobacter jejuni
Ruoyu Gu et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni
Amera Gibreel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Development of macrolide-resistant Campylobacter in broilers administered subtherapeutic or therapeutic concentrations of tylosin
Scott R. Ladely et al.
JOURNAL OF FOOD PROTECTION (2007)
Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickensv
Jun Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Regional and seasonal differences in incidence and antibiotic resistance of Campylobacter from a nationwide surveillance study in The Netherlands:: an overview of 2000-2004
B. C. van Hees et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Comparison of antimicrobial resistance of Campylobacter jejuni isolated from humans, chickens, raw milk, and environmental water in Quebec
Simon Levesque et al.
JOURNAL OF FOOD PROTECTION (2007)
New consensus guidelines from the clinical and laboratory standards institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria
James H. Jorgensen et al.
CLINICAL INFECTIOUS DISEASES (2007)
Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli
Cedric Cagliero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Macrolide resistance in Campylobacter jejuni and Campylobacter coli
Amera Gibreel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli
C Cagliero et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
The bacterial ribosome as a target for antibiotics
J Poehlsgaard et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Bile salts modulate expression of the CmeABC multidrug efflux pump in Campylobacter jejuni
J Lin et al.
JOURNAL OF BACTERIOLOGY (2005)
Molecular basis of macrolide resistance in Campylobacter:: role of efflux pumps and target mutations
L Mamelli et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli
BL Ge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Macrolide resistance in Campylobacter jejuni and Campylobacter coli:: Molecular mechanism and stability of the resistance phenotype
A Gibreel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
The TetR family of transcriptional repressors
JL Ramos et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2005)
Evidence for multiple-antibiotic resistance in Campylobacter jejuni not mediated by CmeB or CmeF
L Pumbwe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni
J Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics
MC Roberts
MOLECULAR BIOTECHNOLOGY (2004)
L22 ribosomal protein and effect of its mutation on ribosome resistance to erythromycin
N Davydova et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus
B Malbruny et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
CmeABC functions as a multidrug efflux system in Campylobacter jejuni
J Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Antimicrobial use and resistance in animals
SA McEwen et al.
CLINICAL INFECTIOUS DISEASES (2002)